Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc.

Multiple Scientific Posters Supporting the Efficacy, Safety and Tolerability of Once-daily Latuda® (lurasidone) are Presented at the 27th ECNP Congress

Berlin (ots/PRNewswire) - Takeda Pharmaceuticals International GmbH ("Takeda") and Sunovion Pharmaceuticals Inc. ("Sunovion") presented new evidence supporting the use of Latuda(R) (lurasidone), an atypical antipsychotic treatment for adults with schizophrenia, during multiple poster sessions at the 27th European ...